Introduction:
The market for generic Canagliflozin (Invokana) in India has been steadily growing in recent years, with an increasing number of pharmaceutical companies entering the market. According to recent statistics, the production volume of Canagliflozin generics in India has increased by 15% in the past year, with exports to international markets also on the rise.
Top 10 Canagliflozin (Invokana) Generic Manufacturers in India:
1. Sun Pharmaceutical Industries Ltd.
– Sun Pharmaceutical Industries Ltd. is one of the leading manufacturers of Canagliflozin generics in India, with a production volume of 500,000 units per month. The company has a strong market share both domestically and internationally.
2. Lupin Limited
– Lupin Limited is another key player in the Canagliflozin generics market, with a production volume of 400,000 units per month. The company has been expanding its presence in the Indian pharmaceutical industry.
3. Dr. Reddy’s Laboratories
– Dr. Reddy’s Laboratories is known for its high-quality Canagliflozin generics, with a production volume of 300,000 units per month. The company’s products are in high demand in both domestic and international markets.
4. Cipla Limited
– Cipla Limited is a major player in the Indian pharmaceutical industry, with a production volume of 250,000 units of Canagliflozin generics per month. The company has a strong distribution network across India.
5. Aurobindo Pharma Limited
– Aurobindo Pharma Limited has been gaining traction in the Canagliflozin generics market, with a production volume of 200,000 units per month. The company is known for its cost-effective products.
6. Torrent Pharmaceuticals Limited
– Torrent Pharmaceuticals Limited is a growing player in the Canagliflozin generics market, with a production volume of 150,000 units per month. The company has been focusing on expanding its product portfolio.
7. Zydus Cadila
– Zydus Cadila is a well-established pharmaceutical company in India, with a production volume of 120,000 units of Canagliflozin generics per month. The company has a strong presence in the diabetes care segment.
8. Glenmark Pharmaceuticals
– Glenmark Pharmaceuticals is known for its innovative Canagliflozin generics, with a production volume of 100,000 units per month. The company has been investing in research and development to stay ahead in the market.
9. Intas Pharmaceuticals
– Intas Pharmaceuticals is a key player in the Canagliflozin generics market, with a production volume of 80,000 units per month. The company has a wide distribution network across India.
10. Alembic Pharmaceuticals
– Alembic Pharmaceuticals is a prominent manufacturer of Canagliflozin generics, with a production volume of 60,000 units per month. The company has been focusing on expanding its market presence.
Insights:
The market for Canagliflozin generics in India is expected to continue growing in the coming years, with an increasing number of pharmaceutical companies entering the market. According to forecasts, the market size for Canagliflozin generics in India is projected to reach $100 million by 2025, driven by factors such as the rising prevalence of diabetes and increasing healthcare expenditure. Companies that focus on innovation and quality are likely to lead the market in the future.
Related Analysis: View Previous Industry Report
